Bicycle Therapeutics Plc Adr (BCYC)

Jan 15, 2025

Bicycle Therapeutics' SWOT analysis: platform potential drives stock outlook - Investing.com India

Jan 15, 2025

Jan 13, 2025

Bicycle Therapeutics reports promising cancer drug trial results - Investing.com India

Jan 13, 2025

Jan 07, 2025

Bicycle therapeutics CDO Santiago Arroyo sells shares worth $69,646 - Investing.com India

Jan 07, 2025

Jan 06, 2025

Bicycle Therapeutics CFO Alethia Young sells shares totaling $19,655 - Investing.com

Jan 06, 2025

Jan 06, 2025

Bicycle Therapeutics exec sells $30k in shares - Investing.com

Jan 06, 2025

Jan 06, 2025

Bicycle Therapeutics CAO Travis Thompson sells $67,292 in shares By Investing.com - Investing.com South Africa

Jan 06, 2025

Jan 06, 2025

Bicycle Therapeutics CTO sells shares worth $60,119 By Investing.com - Investing.com South Africa

Jan 06, 2025

Jan 06, 2025

Bicycle Therapeutics CAO Travis Thompson sells $67,292 in shares - Investing.com

Jan 06, 2025

Jan 06, 2025

Bicycle Therapeutics CEO Lee sells shares worth $172,952 By Investing.com - Investing.com South Africa

Jan 06, 2025

Jan 06, 2025

Bicycle Therapeutics CEO Lee sells shares worth $172,952 - Investing.com India

Jan 06, 2025

Dec 19, 2024

Bicycle Therapeutics' SWOT analysis: stock outlook amid clinical trials and cash strength - Investing.com India

Dec 19, 2024

Dec 14, 2024

Bicycle Therapeutics' SWOT analysis: stock's potential rides on clinical data By Investing.com - Investing.com South Africa

Dec 14, 2024

Dec 14, 2024

Bicycle Therapeutics' SWOT analysis: stock's potential rides on clinical data - Investing.com

Dec 14, 2024

Dec 09, 2024

FDA Accepts GSK's Filing for Expanded Use of Nucala in COPD - Yahoo Finance

Dec 09, 2024

Nov 27, 2024

ALEC Stock Tanks as Alzheimer's Drug Fails in Mid-Stage Study - Yahoo Finance

Nov 27, 2024

Nov 25, 2024

Pharmacovigilance and Drug Safety Software Market Size to Reach USD 371.88 Million by 2032, Growing at a 6.76% CAGR – SNS Insider - Yahoo Finance

Nov 25, 2024

Nov 21, 2024

SAGE's Dalzanemdor Fails to Meet Goal in Huntington's Disease Study - Yahoo Finance

Nov 21, 2024

Nov 19, 2024

ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap - Yahoo Finance

Nov 19, 2024

Nov 15, 2024

Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer Therapy - Yahoo Finance

Nov 15, 2024

Nov 13, 2024

Bicycle Therapeutics' SWOT analysis: innovative platform fuels stock's potential - Investing.com India

Nov 13, 2024

Nov 13, 2024

Bicycle Therapeutics' chief accounting officer sells shares worth $157,113 - Investing.com

Nov 13, 2024

Nov 02, 2024

Bicycle Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 02, 2024

Oct 31, 2024

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results - Yahoo Finance

Oct 31, 2024

Oct 28, 2024

Bicycle Therapeutics' SWOT analysis: stock's potential rides on innovative platform - Investing.com India

Oct 28, 2024

Oct 24, 2024

Bicycle Therapeutics retains stock target and Buy rating on promising data - Investing.com

Oct 24, 2024

Oct 23, 2024

Bicycle Therapeutics spotlights cancer treatment targets - Investing.com

Oct 23, 2024

Oct 21, 2024

Novartis Gets CHMP Recommendation for Kisqali in Broader Population - Yahoo Finance

Oct 21, 2024

Oct 19, 2024

Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock? - MSN

Oct 19, 2024

Oct 14, 2024

A company insider recently sold 3,212 shares of Bicycle Therapeutics Plc ADR [BCYC]. Should You also Consider to Sale? – Knox Daily - Knox Daily

Oct 14, 2024

Oct 10, 2024

BCYC’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle

Oct 10, 2024

Oct 08, 2024

Keeping an Eye on Bicycle Therapeutics Plc ADR (BCYC) After Insider Trading Activity - Knox Daily

Oct 08, 2024

Oct 08, 2024

Bicycle Therapeutics Plc ADR (BCYC)’s stock price range in the last year - US Post News

Oct 08, 2024

Oct 05, 2024

Bicycle therapeutics executive sells shares worth over $21k - Investing.com India

Oct 05, 2024

Oct 05, 2024

Bicycle therapeutics executive sells shares to cover tax obligations - Investing.com India

Oct 05, 2024

Oct 04, 2024

Bicycle therapeutics COO sells shares worth over $21k - Investing.com India

Oct 04, 2024

Oct 04, 2024

Bicycle therapeutics CEO sells shares worth over $71k - Investing.com

Oct 04, 2024

Oct 04, 2024

Bicycle therapeutics CTO sells shares worth over $21k - Investing.com

Oct 04, 2024

Oct 04, 2024

Bicycle therapeutics executive sells shares worth over $5,000 - Investing.com

Oct 04, 2024

Oct 03, 2024

CHIEF PROD & SUPPLY CHAIN OFF Hannay Michael Charles Ferguso sale 246 shares of Bicycle Therapeutics Plc ADR [BCYC] – Knox Daily - Knox Daily

Oct 03, 2024

Oct 03, 2024

Bicycle Therapeutics Plc ADR (BCYC)’s stock chart: A technical perspective - US Post News

Oct 03, 2024

Oct 03, 2024

Market Update: Bicycle Therapeutics Plc ADR (BCYC) Sees Negative Movement, Closing at 22.56 - The Dwinnex

Oct 03, 2024

Sep 30, 2024

Bayer Reports Positive Safety Data on Parkinson's Disease Drug - Yahoo Finance

Sep 30, 2024

Sep 27, 2024

Wall Street SWOT: Bicycle Therapeutics stock rides high on cancer drug promise - Investing.com

Sep 27, 2024

Sep 20, 2024

A company insider recently sold 246 shares of Bicycle Therapeutics Plc ADR [BCYC]. Should You Sale? - Knox Daily

Sep 20, 2024

Sep 19, 2024

Nothing is Better Than Bicycle Therapeutics Plc ADR (BCYC) stock at the moment - SETE News

Sep 19, 2024

Sep 17, 2024

RBC Capital Mkts initates Bicycle Therapeutics Plc ADR (BCYC) stock to an Outperform - Knox Daily

Sep 17, 2024

Sep 17, 2024

Metric Analysis: Bicycle Therapeutics Plc ADR (BCYC)’s Key Ratios in the Limelight - The Dwinnex

Sep 17, 2024

Sep 17, 2024

Bicycle Therapeutics Plc ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle

Sep 17, 2024

Sep 17, 2024

Are Bicycle Therapeutics Plc ADR (BCYC) shares a good deal now? - US Post News

Sep 17, 2024

Sep 17, 2024

Hain Celestial Group Inc [HAIN] Investment Guide: What You Need to Know - Knox Daily

Sep 17, 2024

Sep 16, 2024

Bicycle Therapeutics stock maintains Buy rating post-ESMO data By Investing.com - Investing.com UK

Sep 16, 2024